Faculty from Beth Israel Deaconess Medical Center’s CardioVascular Institute and Colleagues Presenting New Advances and Research at American Heart Association Scientific Sessions

Newswise — Faculty from Beth Israel Deaconess Medical Center’s (BIDMC) CardioVascular Institute and colleagues will be presenting new advances and research at the 2018 American Heart Association (AHA) Scientific Sessions, which are being held November 10-12 in Chicago at the McCormick Place Convention Center. Select highlights include:

• Dietary patterns in the U.S. During the past 20 years

November 10, 2018, 9:00 AM - 9:15 AM

Location: S104b

Presenter: Stephen P. Juraschek, MD

• Machine Learning Identifies Heterogeneity of Treatment Effect for the Use of Spironolactone in Heart Failure With Preserved Ejection Fraction: Insights From the TOPCAT Trial

November 10, 2018, 11:30 AM - 12:45 PM

Zone 2, Science and Technology Hall

Presenter: Usman A. Tahir, MD

• Dimethlyguanidino Valeric Acid Predicts Partial Resistance to the Metabolic Health Benefits of Regular Exercise

November 11, 2018, 4:15 PM - 4:25 PM

Location: N230b

Presenter: Jeremy M. Robbins, MD

Select experts available for interview include:

• Robert E. Gerszten, MD (Clinical/research interests: Metabolomics, relationship between cardiac and metabolic diseases)
• Michael Gibson, MD (Clinical/research interests: Interventional cardiology)
• Robert W. Yeh, MD (Clinical/research interests: Coronary and valvular interventions, outcomes research)
• Stephen P. Juraschek, MD (Clinical/research interests: DASH diet, blood pressure, hypertension, orthostatic hypotension)

If any of these presentations pique your interest and you’d like to speak with one of the presenters or experts, please contact Lindsey Diaz-MacInnis at [email protected] or at 617-667-7372. You can also reach the BIDMC communications team member on call through the BIDMC page operator at (617) 667-4700 and asking for pager ID #33880.